Altimmune Inc (NASDAQ:ALT) has a beta value of 0.57 and has seen 1.52 million shares traded in the recent trading session. The company, currently valued at $566.53M, closed the recent trade at $2730000.0 per share which meant it gained $2729992.97 on the day or 1518767% during that session. The ALT stock price is 100.0% off its 52-week high price of $11.16 and 100.0% above the 52-week low of $3.55. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.13 million shares traded. The 3-month trading volume is 2.73 million shares.
The consensus among analysts is that Altimmune Inc (ALT) is Buy stock at the moment, with a recommendation rating of 1.20. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 6 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight.
Altimmune Inc (NASDAQ:ALT) trade information
Over the past 30 days, the shares of Altimmune Inc (NASDAQ:ALT) have changed 24.96%. Short interest in the company has seen 21.98 million shares shorted with days to cover at 9.11.
Wall Street analysts have a consensus price target for the stock at $25, which means that the shares’ value could drop -10919900.0% from the levels at last check today.. The projected low price target is $12.0 while the price target rests at a high of $35.0. In that case, then, we find that the latest price level in today’s session is 100.0% off the targeted high while a plunge would see the stock lose 100.0% from the levels at last check today..
Altimmune Inc (ALT) estimates and forecasts
The company’s shares have lost -16.85% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 3.48% over the past 5 years. Earnings growth for 2025 is a modest 5.69% while over the next 5 years, the company’s earnings are expected to increase by 0.61%.
ALT Dividends
Altimmune Inc is expected to release its next earnings report on 2025-May-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Altimmune Inc (NASDAQ:ALT)’s Major holders
Insiders own 0.76% of the company shares, while shares held by institutions stand at 47.87% with a share float percentage of 48.23%. Investors are also buoyed by the number of investors in a company, with Altimmune Inc having a total of 241.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 5.32 million shares worth more than $35.39 million. As of 2024-06-30, BLACKROCK INC. held 7.5025% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 4.91 million shares as of 2024-06-30. The firm’s total holdings are worth over $32.63 million and represent 6.9181% of shares outstanding.
